The team at NYU Langone’s Cardiovascular Thrombosis Program offers comprehensive care to patients with inherited or acquired clotting disorders, backed by the latest research available. Our team is actively involved with clinical trials and regularly collaborates with expert investigators, clinicians, and statisticians from NYU Langone’s Inherited Arrhythmia Program and Center for the Prevention of Cardiovascular Disease to bring you the most innovative and effective care possible.
A thrombosis is an excessive or dangerous blood clot that forms in a vein or artery. If you develop a blood clot, you may have many questions about why it occurred, the possibility of it happening again, and how to prevent it from reoccurring. Our team of specialists provides complete evaluation, diagnosis, and disease management services for people with clotting conditions or who currently have a blood clot.
U.S. News & World Report’s “Best Hospitals” ranks NYU Langone one of the top hospitals in the country for cardiology and heart surgery.
We treat patients with a variety of thrombotic conditions, including:
We also offer assistance in preventing excessive coagulation of your blood before, during, and after surgery, and the management of antiplatelet therapies, which are medicines that stop blood platelets from sticking together and clotting.
We perform platelet testing, coagulation testing, and genetic testing to help guide anticlotting strategies, and develop a treatment plan tailored especially for you.
530 First Avenue, Schwartz HCC 4F, New York, NY, 10016
Review our forms for new and existing NYU Langone patients.
Free Wi-Fi is available to patients and visitors.